Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Susceptibility mutations for ischemic heart disease.

B G Nordestgaard1, A Tybjaerg-Hansen

  • 1Herlev University Hospitals and The Copenhagen City Heart Study, Copenhagen, Denmark.

Current Atherosclerosis Reports
|December 21, 2000
PubMed
Summary

Genetic variations in apolipoprotein B, lipoprotein lipase, and angiotensin converting enzyme impact cholesterol and triglyceride levels, influencing ischemic heart disease risk. These genetic factors contribute to a small but significant portion of heart disease in the population.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to dietary guidelines and risk of dementia: a prospective cohort study of 94 184 individuals.

Epidemiology and psychiatric sciences·2022
Same author

Cardiac chamber volumes and left ventricular mass in people living with HIV and matched uninfected controls.

HIV medicine·2020
Same author

Contribution of remnant cholesterol to cardiovascular risk.

Journal of internal medicine·2020
Same author

Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Coffee intake protects against symptomatic gallstone disease in the general population: a Mendelian randomization study.

Journal of internal medicine·2019
Same author

Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls: the Copenhagen Comorbidity in HIV Infection (COCOMO) study.

HIV medicine·2019

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Population Health

Background:

  • Genetic polymorphisms are increasingly recognized as determinants of cardiovascular disease risk.
  • Specific gene variants, including those in apolipoprotein B (APOB), lipoprotein lipase (LPL), and angiotensin converting enzyme (ACE), have been associated with lipid metabolism and cardiovascular outcomes.
  • Understanding the population-level impact of these variants is crucial for public health strategies.

Purpose of the Study:

  • To investigate the association between specific genetic mutations in APOB, LPL, and ACE and their impact on plasma lipid levels (cholesterol and triglycerides) and the risk of ischemic heart disease (IHD).
  • To quantify the population-attributable fraction of IHD associated with these genetic variants compared to diabetes mellitus.

Main Methods:

Related Experiment Videos

  • Analysis of genetic variants (APOB Arg3500Gln, APOB Arg3531Cys, LPL Gly188Glu, LPL Asn291Ser, LPL Asp9Asn, ACE DD) within The Copenhagen City Heart Study cohort.
  • Measurement of plasma lipid levels (cholesterol and triglycerides) and angiotensin converting enzyme (ACE) activity.
  • Calculation of odds ratios for IHD associated with each genotype and estimation of population-attributable fractions.

Main Results:

  • APOB Arg3500Gln significantly increased plasma cholesterol by 41%, associated with a sevenfold increased IHD risk.
  • LPL Gly188Glu increased plasma triglycerides by 42% (sevenfold IHD risk), LPL Asn291Ser by 13% (twofold IHD risk in women), and LPL Asp9Asn by 13% (twofold IHD risk in men).
  • ACE DD increased plasma ACE activity by 57% but was not associated with increased IHD risk; diabetes mellitus conferred a threefold IHD risk and accounted for 7% of population-attributable IHD.

Conclusions:

  • Specific mutations in APOB and LPL are significant risk factors for elevated plasma lipids and increase the risk of ischemic heart disease.
  • While these genetic variants contribute to IHD, their overall population-attributable fraction is modest compared to conditions like diabetes mellitus.
  • Genetic screening for these variants may offer insights into individual cardiovascular risk, but population-level interventions targeting major risk factors like diabetes remain paramount.